NovaBridge Biosciences
NBP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $165 | $54 | $68 | $79 |
| Short-Term Investments | $0 | $115 | $105 | $105 |
| Receivables | $2 | $5 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $2 | $4 |
| Total Curr. Assets | $168 | $173 | $177 | $188 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $34 | $31 | $31 | $39 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $39 | $36 | $36 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $207 | $209 | $213 | $233 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $7 | $8 | $11 |
| Total Curr. Liab. | $7 | $8 | $8 | $12 |
| LT Debt | $3 | $3 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $4 | $4 |
| Total Liabilities | $10 | $11 | $12 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,295 | -$1,289 | -$1,286 | -$1,277 |
| AOCI | $37 | $33 | $33 | $42 |
| Other Equity | $1,454 | $1,454 | $1,454 | $1,453 |
| Total Equity | $197 | $198 | $201 | $218 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $207 | $209 | $213 | $233 |
| Net Debt | -$162 | -$50 | -$64 | -$76 |